Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
25 Ergebnisse
| MD0VC0 |  | BridgeBio Pharma Inc./Faktor/Long [2]/MS | - | - | call | BridgeBio Pharma Inc. | 42,067 | 42,067 | 2,006 | 49,834 % | - | Morgan Stanley | |
| MG0JPB | | BridgeBio Pharma Inc./Faktor/Long [3]/MS | - | - | call | BridgeBio Pharma Inc. | 56,093 | 56,093 | 3,030 | 33,108 % | - | Morgan Stanley | |
| MG3VV3 | | BridgeBio Pharma Inc./Faktor/Long [6]/MS | - | - | call | BridgeBio Pharma Inc. | 70,116 | 70,116 | 6,004 | 16,384 % | - | Morgan Stanley | |
| MG6X20 | | BridgeBio Pharma Inc./Faktor/Long [5]/MS | - | - | call | BridgeBio Pharma Inc. | 67,311 | 67,311 | - | 19,729 % | - | Morgan Stanley | |
| MJ42F2 | | BridgeBio Pharma Inc./Faktor/Long [4]/MS | - | - | call | BridgeBio Pharma Inc. | 63,104 | 63,104 | - | 24,746 % | - | Morgan Stanley | |
| MK4BK7 | | BridgeBio Pharma Inc./Faktor/Long [5]/MS | - | - | call | BridgeBio Pharma Inc. | 67,311 | 67,311 | - | 19,729 % | - | Morgan Stanley | |
| MM6SPY | | BridgeBio Pharma Inc./Faktor/Short [2]/MS | - | - | put | BridgeBio Pharma Inc. | 126,177 | 126,177 | 1,879 | 50,470 % | - | Morgan Stanley | |
| MM6SPZ | | BridgeBio Pharma Inc./Faktor/Short [3]/MS | - | - | put | BridgeBio Pharma Inc. | 112,157 | 112,157 | 2,909 | 33,751 % | - | Morgan Stanley | |
| MM6SQ0 | | BridgeBio Pharma Inc./Faktor/Short [4]/MS | - | - | put | BridgeBio Pharma Inc. | 105,148 | 105,148 | - | 25,392 % | - | Morgan Stanley | |
| MN5GF5 | | BridgeBio Pharma Inc./Faktor/Short [5]/MS | - | - | put | BridgeBio Pharma Inc. | 100,942 | 100,942 | - | 20,376 % | - | Morgan Stanley | |
| MR3H7P | | BridgeBio Pharma Inc./Faktor/Long [4]/MS | - | - | call | BridgeBio Pharma Inc. | 63,104 | 63,104 | - | 24,746 % | - | Morgan Stanley | |
| MR47CG | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 42,104 | 42,104 | 1,963 | 49,789 % | - | Morgan Stanley | |
| MR47CH | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 44,109 | 44,109 | 2,063 | 47,398 % | - | Morgan Stanley | |
| MR47CJ | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 46,114 | 46,114 | 2,173 | 45,007 % | - | Morgan Stanley | |
| MR47CK | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 48,119 | 48,119 | 2,292 | 42,616 % | - | Morgan Stanley | |
| MR47CL | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 50,124 | 50,124 | 2,414 | 40,225 % | - | Morgan Stanley | |
| MR47CM | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 52,129 | 52,129 | 2,570 | 37,834 % | - | Morgan Stanley | |
| MR47CN | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 54,134 | 54,134 | 2,741 | 35,443 % | - | Morgan Stanley | |
| MR47CP | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 56,139 | 56,139 | 2,918 | 33,052 % | - | Morgan Stanley | |
| MR4DT9 | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 70,095 | 70,095 | 5,446 | 16,409 % | - | Morgan Stanley | |
| MR4DVQ | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 37,087 | 40,000 | 1,772 | 52,299 % | - | Morgan Stanley | |
| MR4E01 | | BridgeBio Pharma Inc./KO/Put [endlos]/MS | - | - | put | BridgeBio Pharma Inc. | 99,986 | 99,986 | 4,935 | 19,236 % | - | Morgan Stanley | |
| MR4E5A | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 55,631 | 60,000 | 2,926 | 28,448 % | - | Morgan Stanley | |
| MR4E5B | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 64,903 | 70,000 | 4,284 | 16,523 % | - | Morgan Stanley | |
| MR4E5C | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 69,539 | 75,000 | 5,655 | 10,560 % | - | Morgan Stanley |